Clinical Trial Update: Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study

View source ↗

Summary

This ClinicalTrials.gov entry describes a pilot study collecting endometrial cancer-derived organoids to evaluate the efficacy of PARP inhibitors, with recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• PARP inhibitors

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Endometrial Cancer | Status: RECRUITING